These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 19020308)

  • 1. Zalypsis: a novel marine-derived compound with potent antimyeloma activity that reveals high sensitivity of malignant plasma cells to DNA double-strand breaks.
    Ocio EM; Maiso P; Chen X; Garayoa M; Alvarez-Fernández S; San-Segundo L; Vilanova D; López-Corral L; Montero JC; Hernández-Iglesias T; de Alava E; Galmarini C; Avilés P; Cuevas C; San-Miguel JF; Pandiella A
    Blood; 2009 Apr; 113(16):3781-91. PubMed ID: 19020308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zalypsis has in vitro activity in acute myeloid blasts and leukemic progenitor cells through the induction of a DNA damage response.
    Colado E; Paíno T; Maiso P; Ocio EM; Chen X; Alvarez-Fernández S; Gutiérrez NC; Martín-Sánchez J; Flores-Montero J; San Segundo L; Garayoa M; Fernández-Lázaro D; Vidriales MB; Galmarini CM; Avilés P; Cuevas C; Pandiella A; San-Miguel JF
    Haematologica; 2011 May; 96(5):687-95. PubMed ID: 21330323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TIS21(/BTG2/PC3) accelerates the repair of DNA double strand breaks by enhancing Mre11 methylation and blocking damage signal transfer to the Chk2(T68)-p53(S20) pathway.
    Choi KS; Kim JY; Lim SK; Choi YW; Kim YH; Kang SY; Park TJ; Lim IK
    DNA Repair (Amst); 2012 Dec; 11(12):965-75. PubMed ID: 23089312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular pharmacology and antitumor activity of Zalypsis in several human cancer cell lines.
    Leal JF; García-Hernández V; Moneo V; Domingo A; Bueren-Calabuig JA; Negri A; Gago F; Guillén-Navarro MJ; Avilés P; Cuevas C; García-Fernández LF; Galmarini CM
    Biochem Pharmacol; 2009 Jul; 78(2):162-70. PubMed ID: 19427997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic DNA-damaging effect in multiple myeloma with the combination of zalypsis, bortezomib and dexamethasone.
    López-Iglesias AA; González-Méndez L; San-Segundo L; Herrero AB; Hernández-García S; Martín-Sánchez M; Gutiérrez NC; Paíno T; Avilés P; Mateos MV; San-Miguel JF; Garayoa M; Ocio EM
    Haematologica; 2017 Jan; 102(1):168-175. PubMed ID: 27540138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of in vitro and in vivo biological effects of trabectedin, lurbinectedin (PM01183) and Zalypsis® (PM00104).
    Romano M; Frapolli R; Zangarini M; Bello E; Porcu L; Galmarini CM; García-Fernández LF; Cuevas C; Allavena P; Erba E; D'Incalci M
    Int J Cancer; 2013 Nov; 133(9):2024-33. PubMed ID: 23588839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of p53 on Ser15 during cell cycle caused by Topo I and Topo II inhibitors in relation to ATM and Chk2 activation.
    Zhao H; Traganos F; Darzynkiewicz Z
    Cell Cycle; 2008 Oct; 7(19):3048-55. PubMed ID: 18802408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D-501036, a novel selenophene-based triheterocycle derivative, exhibits potent in vitro and in vivo antitumoral activity which involves DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation.
    Juang SH; Lung CC; Hsu PC; Hsu KS; Li YC; Hong PC; Shiah HS; Kuo CC; Huang CW; Wang YC; Huang L; Chen TS; Chen SF; Fu KC; Hsu CL; Lin MJ; Chang CJ; Ashendel CL; Chan TC; Chou KM; Chang JY
    Mol Cancer Ther; 2007 Jan; 6(1):193-202. PubMed ID: 17237279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical anti-myeloma activity of EDO-S101, a new bendamustine-derived molecule with added HDACi activity, through potent DNA damage induction and impairment of DNA repair.
    López-Iglesias AA; Herrero AB; Chesi M; San-Segundo L; González-Méndez L; Hernández-García S; Misiewicz-Krzeminska I; Quwaider D; Martín-Sánchez M; Primo D; Paíno T; Bergsagel PL; Mehrling T; González-Díaz M; San-Miguel JF; Mateos MV; Gutiérrez NC; Garayoa M; Ocio EM
    J Hematol Oncol; 2017 Jun; 10(1):127. PubMed ID: 28633670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arsenic trioxide augments Chk2/p53-mediated apoptosis by inhibiting oncogenic Wip1 phosphatase.
    Yoda A; Toyoshima K; Watanabe Y; Onishi N; Hazaka Y; Tsukuda Y; Tsukada J; Kondo T; Tanaka Y; Minami Y
    J Biol Chem; 2008 Jul; 283(27):18969-79. PubMed ID: 18482988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxaliplatin-induced gamma-H2AX activation via both p53-dependent and -independent pathways but is not associated with cell cycle arrest in human colorectal cancer cells.
    Chiu SJ; Lee YJ; Hsu TS; Chen WS
    Chem Biol Interact; 2009 Dec; 182(2-3):173-82. PubMed ID: 19735649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting aurora kinases as therapy in multiple myeloma.
    Shi Y; Reiman T; Li W; Maxwell CA; Sen S; Pilarski L; Daniels TR; Penichet ML; Feldman R; Lichtenstein A
    Blood; 2007 May; 109(9):3915-21. PubMed ID: 17213289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional interaction of H2AX, NBS1, and p53 in ATM-dependent DNA damage responses and tumor suppression.
    Kang J; Ferguson D; Song H; Bassing C; Eckersdorff M; Alt FW; Xu Y
    Mol Cell Biol; 2005 Jan; 25(2):661-70. PubMed ID: 15632067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Implications of p53 Status on Cancer Cell Fate Following Exposure to Ionizing Radiation and the DNA-PK Inhibitor M3814.
    Sun Q; Guo Y; Liu X; Czauderna F; Carr MI; Zenke FT; Blaukat A; Vassilev LT
    Mol Cancer Res; 2019 Dec; 17(12):2457-2468. PubMed ID: 31551253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for ongoing DNA damage in multiple myeloma cells as revealed by constitutive phosphorylation of H2AX.
    Walters DK; Wu X; Tschumper RC; Arendt BK; Huddleston PM; Henderson KJ; Dispenzieri A; Jelinek DF
    Leukemia; 2011 Aug; 25(8):1344-53. PubMed ID: 21566653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ghrelin Prevents Cisplatin-Induced Testicular Damage by Facilitating Repair of DNA Double Strand Breaks Through Activation of p53 in Mice.
    Garcia JM; Chen JA; Guillory B; Donehower LA; Smith RG; Lamb DJ
    Biol Reprod; 2015 Jul; 93(1):24. PubMed ID: 26019260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of ATM phosphorylation on Ser-1981 induced by DNA topoisomerase I and II inhibitors in relation to Ser-139-histone H2AX phosphorylation, cell cycle phase, and apoptosis.
    Kurose A; Tanaka T; Huang X; Halicka HD; Traganos F; Dai W; Darzynkiewicz Z
    Cytometry A; 2005 Nov; 68(1):1-9. PubMed ID: 16184611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E2F1-dependent pathways are involved in amonafide analogue 7-d-induced DNA damage, G2/M arrest, and apoptosis in p53-deficient K562 cells.
    Li Y; Shao J; Shen K; Xu Y; Liu J; Qian X
    J Cell Biochem; 2012 Oct; 113(10):3165-77. PubMed ID: 22593008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of Histone H2AX Phosphorylation in DT40 Cells.
    Nishihara K; Shahane SA; Xia M
    Methods Mol Biol; 2016; 1473():71-6. PubMed ID: 27518625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Combination of SAHA and Quinacrine Is Effective in Inducing Cancer Cell Death in Upper Gastrointestinal Cancers.
    Zhu S; Chen Z; Wang L; Peng D; Belkhiri A; Lockhart AC; El-Rifai W
    Clin Cancer Res; 2018 Apr; 24(8):1905-1916. PubMed ID: 29386219
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.